Demetallica’s cash position has fallen dramatically since completion of the IPO (and associated
transactions) with more than $10 million spent in 5 months.
At 30 September 2022, Demetallica’s available cash position was approximately $7 million and
given Demetallica’s overhead expenses of approximately $2 million annually, current
expenditure rates and costs in relation to the Offer is expected to fall to less than $5 million by
year end.
-----
Just keep buying on market. The longer this drags the more nervous the shareholders of DRM would be.
The board that sits on DRM doesn't have the technical expertise nor the financial backing to develop this asset.
Not to mention that they just approved the sale at .22 in June 2022.
So now appraently, in less than 3 months it worth much more ?
Very high chance that A1M is going to close this whether DRM accepts it or not.
If they don't close this offer, then DRM would have a very tough time raising cash later in the year.
Not to mention the price will drag lower than where it began. below 18 cents.
- Forums
- ASX - By Stock
- Ann: Supplementary Bidder's Statement
Demetallica’s cash position has fallen dramatically since...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A1M (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
0.015(3.13%) |
Mkt cap ! $228.9M |
Open | High | Low | Value | Volume |
48.5¢ | 50.3¢ | 48.0¢ | $880.2K | 1.781M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 124683 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 172764 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 124683 | 0.490 |
1 | 8000 | 0.485 |
4 | 58631 | 0.480 |
1 | 2106 | 0.475 |
6 | 33329 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 172764 | 4 |
0.505 | 103502 | 4 |
0.510 | 154471 | 3 |
0.515 | 16708 | 3 |
0.520 | 34900 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
49.5¢ |
  |
Change
0.015 ( 2.15 %) |
|||
Open | High | Low | Volume | ||
48.0¢ | 50.5¢ | 48.0¢ | 655103 | ||
Last updated 15.58pm 06/05/2024 ? |
Featured News
A1M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online